Cargando…
Analysis of factors influencing the distribution of 131-I in combined treatment of Licartin with transcatheter arterial chemoembolization in primary hepatic carcinoma
OBJECTIVE: To analyze the factors influencing the distribution of 131-I in the liver of patients with advanced hepatic carcinoma treated with the combination of Licartin ((131)I Metuximab) and transcatheter arterial chemoembolization (TACE). This study provides a reference and basis for the clinic o...
Autores principales: | Tang, Ming, Li, Wen-Liang, Li, Jia-Yu, Lv, Juan, Chen, Fu-Kun, Zhu, Jia-Lun, Liu, Peng-Jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10040873/ https://www.ncbi.nlm.nih.gov/pubmed/36994225 http://dx.doi.org/10.3389/fonc.2022.993948 |
Ejemplares similares
-
Infiltrative Hepatocellular Carcinoma: Transcatheter Arterial Chemoembolization Versus Hepatic Arterial Infusion Chemotherapy
por: An, Chao, et al.
Publicado: (2021) -
Hepatic Artery Injection of (131)I-Metuximab Combined with Transcatheter Arterial Chemoembolization for Unresectable Hepatocellular Carcinoma: A Prospective Nonrandomized, Multicenter Clinical Trial
por: Chen, Hui, et al.
Publicado: (2022) -
Ruptured Hepatic Carcinoma After Transcatheter Arterial Chemoembolization()
por: Jia, Zhongzhi, et al.
Publicado: (2013) -
Transcatheter Arterial Chemoembolization Plus (131)I-Labelled Metuximab versus Transcatheter Arterial Chemoembolization Alone in Intermediate/Advanced Stage Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis
por: Zhu, Ze-xin, et al.
Publicado: (2016) -
Meta-analysis of transcatheter arterial chemoembolization plus radiofrequency ablation versus transcatheter arterial chemoembolization alone for hepatocellular carcinoma
por: Yang, De-jun, et al.
Publicado: (2016)